Last 204.30
Change Today -3.90 / -1.87%
Volume 296.1K
ITMR On Other Exchanges
Tel Aviv
As of 7:24 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

itamar medical ltd (ITMR) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/3/14 - $268.00
52 Week Low
09/9/13 - $128.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ITAMAR MEDICAL LTD (ITMR)

Related News

No related news articles were found.

itamar medical ltd (ITMR) Related Businessweek News

No Related Businessweek News Found

itamar medical ltd (ITMR) Details

Itamar Medical Ltd. develops, markets, and sells diagnostic medical devices. Its medical devices are based on Peripheral Arterial Tone (PAT) signal, a non-invasive window to the cardiovascular system and the autonomic nervous system. The company offers EndoPAT, a medical device for noninvasive endothelial function assessment used in preeminent clinical and research institutions, epidemiological population based studies (such as Framingham Heart Study), and pharmaceutical clinical phase studies; WatchPAT, a medical device used for the detection of ambulatory sleep disorder; and devices for detecting erectile dysfunction. It also provides pharmaceutical products for drug development and companion diagnostics. The company was founded in 1997 and is headquartered in Caesarea, Israel.

Founded in 1997

itamar medical ltd (ITMR) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

itamar medical ltd (ITMR) Key Developments

Itamar Medical Ltd. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 03:40 PM

Itamar Medical Ltd. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 03:40 PM. Venue: The Westin Grand Central Hotel, New York, New York, United States.

Thorne Research, Inc Enters into Three-Year Non-Exclusive Co-Marketing Agreement with Itamar Medical, Inc

Thorne Research Inc. announced that the company has entered into a three-year non-exclusive co-marketing agreement with Itamar Medical Inc., to market Itamar's EndoPAT and WatchPAT. Under the agreement, Thorne Research will receive marketing rights for the EndoPAT and WatchPAT devices and related disposables (finger probes) in the United States. Thorne Research will incorporate EndoPAT and WatchPAT training materials into its training events for healthcare practitioners, which also provide information on its TruCardia line of nutritional supplement products to support cardiovascular health.

Itamar Medical Ltd., Special/Extraordinary Shareholders Meeting, Jan 14, 2014

Itamar Medical Ltd., Special/Extraordinary Shareholders Meeting, Jan 14, 2014., at 10:00 Israel Standard Time.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ITMR:IT 204.30 -3.90

ITMR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ITMR.
View Industry Companies

Industry Analysis


Industry Average

Valuation ITMR Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ITAMAR MEDICAL LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at